🔴 Neurosense Therapeutics is trading 13% down today, extending a week-long slide on no fresh news

Neurosense Therapeutics is trading 13% down at $0.51 in pre-market, extending a steady slide from $0.70 on July 21.

• The stock has seen a consistent decline over the past week, falling from $0.70 on July 21 to $0.59 on July 27.
• There are currently no fresh company-specific headlines, earnings releases, or analyst calls linked to the move.
• The price action suggests ongoing weakness in the name rather than a new fundamental catalyst.